BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37906009)

  • 21. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
    Kim KJ; Kim SG; Tan J; Shen X; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
    Eur J Cancer; 2020 Jan; 124():161-169. PubMed ID: 31790974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
    Back K; Kim JS; Kim JH; Choe JH
    Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computed Tomography for Detecting Cervical Lymph Node Metastasis in Patients Who Have Papillary Thyroid Microcarcinoma with Tumor Characteristics Appropriate for Active Surveillance.
    Lee DH; Kim YK; Yu HW; Choi JY; Park SY; Moon JH
    Thyroid; 2019 Nov; 29(11):1653-1659. PubMed ID: 31436140
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-Term Follow-Up Results of Ultrasound-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: More Than 5-Year Follow-Up for 84 Tumors.
    Cho SJ; Baek SM; Lim HK; Lee KD; Son JM; Baek JH
    Thyroid; 2020 Dec; 30(12):1745-1751. PubMed ID: 32375570
    [No Abstract]   [Full Text] [Related]  

  • 25. Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 Patients.
    Yan L; Zhang M; Song Q; Luo Y
    Thyroid; 2021 Nov; 31(11):1662-1672. PubMed ID: 34269611
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of Initial Treatment Choice on 2-year Quality of Life in Patients with Low-risk Papillary Thyroid Microcarcinoma.
    Moon JH; Ryu CH; Cho SW; Choi JY; Chung EJ; Hah JH; Hwangbo Y; Jeong WJ; Jung YS; Kim JH; Kim MJ; Kim SJ; Kim YK; Lee CY; Lee EK; Lee JY; Lee KE; Lee YJ; Lee Y; Yu HW; Park DJ; Ryu J; Park YJ
    J Clin Endocrinol Metab; 2021 Mar; 106(3):724-735. PubMed ID: 33248442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases.
    Medas F; Canu GL; Cappellacci F; Boi F; Lai ML; Erdas E; Calò PG
    Front Endocrinol (Lausanne); 2020; 11():551. PubMed ID: 32982963
    [No Abstract]   [Full Text] [Related]  

  • 28. [Risk Factors for central lymph node metastasis in 1 988 papillary thyroid microcarcinoma patients].
    Li XJ; Yang L; Ma BL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(1):52-57. PubMed ID: 29774686
    [No Abstract]   [Full Text] [Related]  

  • 29. Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status.
    Yamamoto M; Miyauchi A; Ito Y; Fujishima M; Sasaki T; Kudo T
    Thyroid; 2023 Oct; 33(10):1182-1189. PubMed ID: 37310904
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk factors of papillary thyroid microcarcinoma that predispose patients to local recurrence.
    Kaliszewski K; Diakowska D; Rzeszutko M; Nowak Ł; Aporowicz M; Wojtczak B; Sutkowski K; Rudnicki J
    PLoS One; 2020; 15(12):e0244930. PubMed ID: 33382852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Papillary Thyroid Microcarcinoma: A Nomogram Based on Clinical and Ultrasound Features to Improve the Prediction of Lymph Node Metastases in the Central Compartment.
    Ye J; Feng JW; Wu WX; Hu J; Hong LZ; Qin AC; Shi WH; Jiang Y
    Front Endocrinol (Lausanne); 2021; 12():770824. PubMed ID: 35095755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papillary thyroid microcarcinoma might progress during pregnancy.
    Shindo H; Amino N; Ito Y; Kihara M; Kobayashi K; Miya A; Hirokawa M; Miyauchi A
    Thyroid; 2014 May; 24(5):840-4. PubMed ID: 24397849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation.
    Ito Y; Miyauchi A; Kihara M; Higashiyama T; Kobayashi K; Miya A
    Thyroid; 2014 Jan; 24(1):27-34. PubMed ID: 24001104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of the diagnostic value of high frequency ultrasound and ultrasound-guided fine needle aspiration biopsy in papillary thyroid microcarcinoma].
    Qin J; Zhang S; Li G; Liu S; Shi X; Wu J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Aug; 35(8):718-723. PubMed ID: 34304533
    [No Abstract]   [Full Text] [Related]  

  • 35. Predictive features of central lymph node metastasis in papillary thyroid microcarcinoma: Roles of active surveillance in over-treatment.
    Han B; Hao S; Wu J; Fang J; Han Z
    Front Med (Lausanne); 2022; 9():906648. PubMed ID: 36226144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma.
    Sasaki T; Miyauchi A; Ito Y; Kudo T; Kanemura N; Sano T; Kawano S; Yamamoto M; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Miya A
    Thyroid; 2021 Feb; 31(2):217-223. PubMed ID: 32664805
    [No Abstract]   [Full Text] [Related]  

  • 37. [A single-center study on the oncological outcomes of active surveillance of thyroid nodules measuring≤1 cm with highly suspicious ultrasound features].
    Liu CH; Zhao H; Xia Y; Cao Y; Zhang LY; Zhao Y; Gao LY; Liu RF; Liu YW; Liu HF; Meng ZL; Liu SZ; Lu Y; Palashate Y; Li XY
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(40):3186-3192. PubMed ID: 37879872
    [No Abstract]   [Full Text] [Related]  

  • 38. Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea.
    Kwon H; Oh HS; Kim M; Park S; Jeon MJ; Kim WG; Kim WB; Shong YK; Song DE; Baek JH; Chung KW; Kim TY
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1917-1925. PubMed ID: 28323932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for skip metastasis in patients with papillary thyroid microcarcinoma.
    Wu X; Li B; Zheng C; He X
    Cancer Med; 2023 Mar; 12(6):7560-7566. PubMed ID: 36479912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of Life in Patients with Papillary Thyroid Microcarcinoma Managed by Active Surveillance or Lobectomy: A Cross-Sectional Study.
    Jeon MJ; Lee YM; Sung TY; Han M; Shin YW; Kim WG; Kim TY; Chung KW; Shong YK; Kim WB
    Thyroid; 2019 Jul; 29(7):956-962. PubMed ID: 31038017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.